Results 71 to 80 of about 10,338 (183)

Enantiospecific pharmacokinetics of metoprolol in CYP2D6 ultra-rapid metabolizers and correlation with exercise-induced heart rate

open access: yes, 2008
Objective Our objective was to study the enantioselective pharmacokinetics of metoprolol in CYP2D6 ultra-rapid metabolizers (UM) compared with extensive (EM) and poor (PM) metabolizers to quantify differential effects of metoprolol enantiomers on the ...
Bauer, Steffen   +7 more
core   +1 more source

Molecularly Imprinted Polymer Based PVC-Membrane-Coated Graphite Electrode for the Determination of Metoprolol

open access: yesInternational Journal of Electrochemical Science, 2010
A PVC membrane based on metoprolol molecularly imprinted polymer (MIP) coated directly on graphite electrode for determination of metoprolol in real sample is described.
Mohammad Saber Tehrani   +3 more
doaj   +1 more source

Bridging the Gap in Headache Care: Insights From the International Headache Society Survey in Nepal

open access: yesHealth Care Science, EarlyView.
Distinct relationships exist between urban and rural healthcare settings and key components of headache care in Nepal. Urban providers are more likely to be trained in migraine management, prescribe migraine‐specific medications, higher headache patient load and serve more specific adult group.
Rajeev Ojha   +13 more
wiley   +1 more source

Pharmacokinetics of metoprolol tartrate in patients with and without controlled arterial hypertension

open access: yesФармакокинетика и Фармакодинамика
Background. Metoprolol is a selective beta-blocker that is most commonly used in the pharmacotherapy of cardiovascular diseases, including hypertension (AH).Objective.
S. V. Seleznev   +3 more
doaj   +1 more source

Metoprolol Dose Equivalence in Adult Men and Women Based on Gender Differences: Pharmacokinetic Modeling and Simulations

open access: yesMedical Sciences, 2016
Recent meta-analyses and publications over the past 15 years have provided evidence showing there are considerable gender differences in the pharmacokinetics of metoprolol.
Andy R. Eugene
doaj   +1 more source

Metoprolol v. clonidine in the prophylactic treatment of migraine.

open access: yes, 1985
peer reviewedIn a double-blind, cross-over trial, the migraine prophylactic effect of the beta 1-adrenoceptor antagonist metoprolol was compared with that of clonidine. The dosage of metoprolol was 50 mg b.i.d.
Louis, P., Schoenen, Jean, Hedman, C.
core   +1 more source

Metoprolol use is associated with improved outcomes in patients with sepsis-induced cardiomyopathy: an analysis of the MIMIC-IV database

open access: yesBMC Cardiovascular Disorders
Background Metoprolol is commonly administered to critically ill patients; however, its effect on mortality in patients with sepsis-induced cardiomyopathy (SICM) remains uncertain.
Liping Zhong   +3 more
doaj   +1 more source

A real‐world analysis of AI chatbot performance for medicines information enquiries

open access: yesJournal of Pharmacy Practice and Research, EarlyView.
Abstract Background The provision of medicines information (MI) services requires interpretation and clinical judgement of complex scenarios by pharmacists. To date, few studies have assessed the performance of artificial intelligence (AI) chatbots to assist pharmacists providing MI advice.
Duncan Yorkston   +2 more
wiley   +1 more source

Effect on mortality of metoprolol in acute myocardial infarction

open access: yes, 1981
The effect of metoprolol on mortality was compared with that of placebo in a double-blind randomised trial in patients with definite or suspected acute myocardial infarction.
Hjalmarson, Å   +29 more
core   +1 more source

EFFECT OF METOPROLOL ON COGNITIVE FUNCTION IN HYPERTENSIVE PATIENTS OF YOUNG TO MIDDLE AGE

open access: yesРациональная фармакотерапия в кардиологии, 2016
Aim. To evaluate the effect of metoprolol tartrate on blood pressure (BP) and cognitive function in young to middle aged patients with essential hypertension (HT).Material and methods.
S. A. Smakotina   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy